Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Author: Benzinga Insights | October 30, 2024 07:08am

Gainers

  • Ensysce Biosciences (NASDAQ:ENSC) shares increased by 21.6% to $0.5 during Wednesday's pre-market session. The company's market cap stands at $7.5 million.
  • CalciMedica (NASDAQ:CALC) stock rose 18.32% to $4.65. The company's market cap stands at $49.9 million.
  • Matinas BioPharma Hldgs (AMEX:MTNB) shares increased by 18.27% to $3.3. The company's market cap stands at $16.5 million.
  • AtriCure (NASDAQ:ATRC) stock increased by 15.52% to $34.0. The market value of their outstanding shares is at $1.6 billion. The company's, Q3 earnings came out yesterday.
  • Cue Biopharma (NASDAQ:CUE) stock rose 15.38% to $1.95. The market value of their outstanding shares is at $117.4 million.
  • HOOKIPA Pharma (NASDAQ:HOOK) shares increased by 14.47% to $4.27. The company's market cap stands at $42.2 million.

Losers

  • Applied DNA Sciences (NASDAQ:APDN) stock fell 41.7% to $0.18 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.9 million.
  • AnaptysBio (NASDAQ:ANAB) shares fell 21.43% to $24.2. The company's market cap stands at $730.8 million.
  • Spero Therapeutics (NASDAQ:SPRO) stock decreased by 19.85% to $1.05. The market value of their outstanding shares is at $56.7 million.
  • GlycoMimetics (NASDAQ:GLYC) stock fell 14.31% to $0.42. The market value of their outstanding shares is at $27.0 million.
  • Tempest Therapeutics (NASDAQ:TPST) shares declined by 13.65% to $0.95. The company's market cap stands at $23.9 million.
  • CVRx (NASDAQ:CVRX) shares fell 11.92% to $9.46. The market value of their outstanding shares is at $205.3 million. As per the news, the Q3 earnings report came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ANAB APDN ATRC CALC CUE CVRX ENSC GLYC HOOK MTNB SPRO TPST

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist